Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Bifidobacterium pseudolongum Strain PV8-2, Isolated from a Stool Sample of an Anemic Kenyan Infant.

ABSTRACT: The complete genome sequence of Bifidobacterium pseudolongum PV8-2, isolated from feces of an anemic Kenyan infant, was determined using single-molecule real-time (SMRT) technology. The genome consists of a 2-Mbp chromosome and a 4-kb plasmid.

SUBMITTER: Vazquez-Gutierrez P

PROVIDER: S-EPMC4319582 | biostudies-literature | 2015 Jan

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

Bifidobacterium pseudolongum Strain PV8-2, Isolated from a Stool Sample of an Anemic Kenyan Infant.

Vazquez-Gutierrez Pamela P Lacroix Christophe C Chassard Christophe C Klumpp Jochen J Stevens Marc J A MJ Jans Christoph C

Genome announcements 20150122 1

The complete genome sequence of Bifidobacterium pseudolongum PV8-2, isolated from feces of an anemic Kenyan infant, was determined using single-molecule real-time (SMRT) technology. The genome consists of a 2-Mbp chromosome and a 4-kb plasmid. ...[more]

PMID: 25614573

Similar Datasets

Complete and Assembled Genome Sequence of Bifidobacterium kashiwanohense PV20-2, Isolated from the Feces of an Anemic Kenyan Infant.

Project description:The complete genome sequence of Bifidobacterium kashiwanohense strain PV20-2, an infant feces isolate, was determined using single-molecule real-time sequencing (SMRT). Hierarchical genome assembly resulted in a completely assembled genome of 2,370,978 bp. The B. kashiwanohense PV20-2 genome is the first completely sequenced and assembled genome of the species.

| S-EPMC4319591 | biostudies-literature

Draft Genome Sequences of a <i>Bifidobacterium</i> Strain and a <i>Bacteroides</i> Strain Isolated from a Human Stool Sample.

Project description:We present draft genome sequences of Bifidobacterium longum subsp. longum JCM 7050 and Bacteroides sp. strain 1_1_30 isolated from a healthy donor's fecal sample obtained from a public stool bank, OpenBiome. Phylogenetic and functional analyses were performed to understand the physiological characteristics and functions of the strains in the human intestine.

| S-EPMC9022498 | biostudies-literature

Infant stool sample

Project description:Infant gut microbiome meta-transcriptomics

| PRJNA505710 | ENA

Complete Genome Sequence of a Strain of Bifidobacterium pseudolongum Isolated from Mouse Feces and Associated with Improved Organ Transplant Outcome.

Project description:Here, we report the complete genome sequence of Bifidobacterium pseudolongum strain UMB-MBP-01, isolated from the feces of C57BL/6J mice. This strain was identified in microbiome profiling studies and associated with improved transplant outcome in a murine model of cardiac heterotypic transplantation.

| S-EPMC5629060 | biostudies-literature

Differential effects of Bifidobacterium pseudolongum strain Patronus and metronidazole in the rat gut.

Project description:In the luminal contents of metronidazole-treated rats, there was a dominant Bifidobacterium species. A strain has been isolated, its 16S rRNA gene has been sequenced, and the strain has been named Bifidobacterium pseudolongum strain Patronus. In this study, using an experimental model of healthy rats, the effects of metronidazole treatment and B. pseudolongum strain Patronus administration on the luminal and mucosa-associated microbiota and on gut oxidation processes were investigated. Metronidazole treatment and the daily gavage of rats with B. pseudolongum strain Patronus increased the numbers of bifidobacteria in cecal contents and in cecal mucosa-associated microbiota compared with those in control rats. Metronidazole reduced the colonic oxidative damage to proteins. This is the first evidence that B. pseudolongum strain Patronus exerts an effect on a biomarker of oxidative damage by reducing the susceptibility to oxidation of proteins in the colon and the small bowel. Antioxidant effects of metronidazole could be linked to the bifidobacterial increase but also to other bacterial modifications.

| S-EPMC2620693 | biostudies-literature

Strain-specific alterations in gut microbiome and host immune responses elicited by tolerogenic Bifidobacterium pseudolongum.

Project description:The beneficial effects attributed to Bifidobacterium are largely attributed to their immunomodulatory capabilities, which are likely to be species- and even strain-specific. However, their strain-specificity in direct and indirect immune modulation remain largely uncharacterized. We have shown that B. pseudolongum UMB-MBP-01, a murine isolate strain, is capable of suppressing inflammation and reducing fibrosis in vivo. To ascertain the mechanism driving this activity and to determine if it is specific to UMB-MBP-01, we compared it to a porcine tropic strain B. pseudolongum ATCC25526 using a combination of cell culture and in vivo experimentation and comparative genomics approaches. Despite many shared features, we demonstrate that these two strains possess distinct genetic repertoires in carbohydrate assimilation, differential activation signatures and cytokine responses signatures in innate immune cells, and differential effects on lymph node morphology with unique local and systemic leukocyte distribution. Importantly, the administration of each B. pseudolongum strain resulted in major divergence in the structure, composition, and function of gut microbiota. This was accompanied by markedly different changes in intestinal transcriptional activities, suggesting strain-specific modulation of the endogenous gut microbiota as a key to immune modulatory host responses. Our study demonstrated a single probiotic strain can influence local, regional, and systemic immunity through both innate and adaptive pathways in a strain-specific manner. It highlights the importance to investigate both the endogenous gut microbiome and the intestinal responses in response to probiotic supplementation, which underpins the mechanisms through which the probiotic strains drive the strain-specific effect to impact health outcomes.

| S-EPMC9852428 | biostudies-literature

Bifidobacterium pseudolongum

Project description:Characterisation of Bifidobacterium induced from prebiotic (galacto-oligosaccharide) supplemented pigs

| PRJNA766512 | ENA

Bifidobacterium pseudolongum

Project description:Isolation and Identification of Bifidobacterium species from feces of captive chimpanzee

| PRJDB5473 | ENA

Bifidobacterium pseudolongum

Project description:Bifidobacterium pseudolongum genome sequencing and assembly

| PRJNA510800 | ENA

Bifidobacterium pseudolongum

Project description:Bifidobacterium pseudolongum overview